Lv71
3540 积分 2023-08-23 加入
A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer
1个月前
已完结
Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review
2个月前
已完结
Tisotumab vedotin in recurrent or metastatic cervical cancer
2个月前
已完结
An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy
2个月前
已完结
Preclinical characterization of XB002, an anti-tissue factor antibody-drug conjugate for the treatment of solid tumors
2个月前
已完结
Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma
2个月前
已完结
Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma
2个月前
已完结
Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes
2个月前
已完结
Phase 1 Study of the Tissue Factor–Targeting Antibody-Drug Conjugate XB002 in Patients with Advanced Solid Tumors (JEWEL-101): Design of Expansion Cohorts for Squamous Cell Carcinoma of the Head and Neck
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
皖公网安备34019202002308
